COVID-19 Seroprevalence in Pregnant Women and Blood Donors
NCT04893057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 797
Last updated 2024-10-04
Summary
The study aims to measure the SARS-CoV-2 seroprevalence (ie. the proportion of people with antibodies against the virus) in pregnant women and blood donors in an administrative area of France, and to determine whether these measures are representative of the general population.
Conditions
- COVID-19 Respiratory Infection
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Principal Investigators
-
Maxime Desmarets, MD, PhD · CHU Besançon
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-15
- Primary Completion
- 2023-01-04
- Completion
- 2023-01-04
Countries
- France
Study Locations
More Related Trials
-
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811 ·Status: COMPLETED ·Phase: NA
-
Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns
NCT04463758 ·Status: UNKNOWN
-
Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19
NCT05092607 ·Status: UNKNOWN ·Phase: NA
-
Serological Study of the Exposure of Personnel to COVID-19
NCT04422977 ·Status: COMPLETED ·Phase: NA
-
ANC COVID-19 Surveillance
NCT07021807 ·Status: COMPLETED
-
COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease
NCT04511949 ·Status: COMPLETED ·Phase: NA
-
Study of the Incidence of SARS-CoV-2 Infection (COVID-19)
NCT04429594 ·Status: RECRUITING ·Phase: NA
-
COVID 19-Caregivers IGg Seroconversion
NCT04353323 ·Status: UNKNOWN
-
Evaluation of the New Variant 501Y.V2 of COVID-19
NCT04906850 ·Status: COMPLETED
-
Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection
NCT04624997 ·Status: UNKNOWN
-
Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital
NCT04385914 ·Status: UNKNOWN
-
Pregnant Women Vaccinated Against Covid-19.
NCT04957953 ·Status: COMPLETED
-
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)
NCT04355351 ·Status: COMPLETED ·Phase: NA
-
The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19)
NCT04844515 ·Status: UNKNOWN
-
Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations
NCT05303168 ·Status: COMPLETED
-
RT-PCR Database Analysis for COVID-19 Infections and Re-infection
NCT04653844 ·Status: UNKNOWN
-
Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
NCT05315583 ·Status: TERMINATED ·Phase: NA
-
CoViD-19 Patient in Reims University Hospital in March to April 2020
NCT04553575 ·Status: COMPLETED
-
Prospective Clinical and Virological Analysis of Healthcare Workers Diagnosed Positive for Covid-19.
NCT04858581 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
NCT04568044 ·Status: ACTIVE_NOT_RECRUITING
-
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution
NCT04664023 ·Status: COMPLETED
-
Evaluating Clinical Parameters of COVID-19 in Pregnancy
NCT04470583 ·Status: UNKNOWN
-
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.
NCT04322279 ·Status: TERMINATED
-
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533 ·Status: COMPLETED ·Phase: NA
-
Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP)
NCT04418375 ·Status: COMPLETED